Hold Torrent Pharmaceuticals: target of Rs 3250: ICICI Direct
ICICI Direct recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 3250 in its research report dated July 28, 2021.
August 02, 2021 / 12:11 PM IST
ICICI Direct's research report on Torrent Pharmaceuticals
Incorporated in 1959, Torrent has a strong presence in domestic and semi-regulated markets and a growing presence in regulated markets. Revenues – India including CRAMs (53%), Brazil (8%), US (16%) and Germany (13%). Torrent is the eighth largest domestic player and is ranked in top 10 for CVS, CNS, V&M, GI and anti-diabetes therapies in India
We change our rating from BUY to HOLD on the stock given recent run up We value Torrent at Rs 3250 i.e. 32x P/E on FY23E EPS
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.